Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …

[HTML][HTML] COVID-19 and cardiovascular diseases

F Mai, R Del Pinto, C Ferri - Journal of cardiology, 2020 - Elsevier
Abstract Infection by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
is responsible for the second pandemic of the XXI century after influenza A in 2009. As of …

Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis: Ivermectin in COVID-19: A meta-analysis

BM Padhy, RR Mohanty, S Das… - Journal of Pharmacy …, 2020 - journals.library.ualberta.ca
The current management of COVID-19 is mostly limited to general supportive care and
symptomatic treatment. Ivermectin is a broad-spectrum anti-parasitic drug used widely for …

COVID-19 and cardiovascular diseases

F Liu, F Liu, L Wang - Journal of molecular cell biology, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) remains a global public health
emergency. Despite being caused by severe acute respiratory syndrome coronavirus 2 …

Emergent drug and nutrition interactions in COVID-19: a comprehensive narrative review

D Ağagündüz, MN Çelik, ME Çıtar Dazıroğlu… - Nutrients, 2021 - mdpi.com
Coronaviruses are a large family of viruses that are known to cause respiratory tract
infections ranging from colds to more severe diseases, such as Middle East Respiratory …

COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development

N Bostanghadiri, P Ziaeefar, MG Mofrad… - BioMed Research …, 2023 - Wiley Online Library
The world is presently in crisis facing an outbreak of a health‐threatening microorganism
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …

[PDF][PDF] COVID-19-more than respiratory disease: a gastroenterologist's perspective.

PC Konturek, IA Harsch, MF Neurath… - Journal of Physiology & …, 2020 - jpp.krakow.pl
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV2) outbreak is the most
dramatic event since World War II. Originating as a cluster of unexplained cases of …

[HTML][HTML] Correlation between COVID-19 and hepatitis B: A systematic review

YF He, ZG Jiang, N Wu, N Bian… - World journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND There is growing evidence that patients with coronavirus disease 2019
(COVID-19) frequently present with liver impairment. Hepatitis B virus (HBV) remains a …

Volatile molecules for COVID‐19: A possible pharmacological strategy?

C Colalto - Drug Development Research, 2020 - Wiley Online Library
COVID‐19 is a novel coronavirus disease with a higher incidence of bilateral pneumonia
and pleural effusion. The high pulmonary tropism and contagiousness of the virus, severe …

Clinical repurposing of medicines is intrinsic to homeopathy: research initiatives on COVID-19 in India

R Varanasi, D Nayak, A Khurana - Homeopathy, 2021 - thieme-connect.com
As at mid-October 2020, the coronavirus disease 2019 (COVID-19) pandemic has been
continuing on the rise across the globe, including in India. Historically, homeopathy has …